EDGAR Filing Documents for 0001193125-12-239393

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-12-239393

Filing Date

2012-05-18

Accepted

2012-05-18 11:08:29

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO.2 TO FORM S-1	d312438ds1a.htm	S-1/A	1692110
2	STOCK INCENTIVE PLAN, AS AMENDED	d312438dex101.htm	EX-10.1	180115
3	FORM OF INDEMNIFICATION AGREEMENT FOR DIRECTORS AND OFFICERS	d312438dex1015.htm	EX-10.15	84200
4	DIRECTOR COMPENSATION POLICY	d312438dex1016.htm	EX-10.16	21165
5	CONSENT OF KPMG LLP	d312438dex231.htm	EX-23.1	1440
7	GRAPHIC	g312438g19e87.jpg	GRAPHIC	40753
8	GRAPHIC	g312438g32u15.jpg	GRAPHIC	16185
9	GRAPHIC	g312438g38a63.jpg	GRAPHIC	37993
10	GRAPHIC	g312438g77l24.jpg	GRAPHIC	2962
11	GRAPHIC	g312438g93t01.jpg	GRAPHIC	14513
12		filename12.htm	CORRESP	11473
	Complete submission text file	0001193125-12-239393.txt		2147194

Mailing Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760

Business Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760 973-993-4867

Durata Therapeutics, Inc. (Filer) CIK: 0001544116 (see all company filings)